QUANTOMTx IQ/OQ Protocol |
LBQ14001 |
Westburg |
each |
EUR 991.9 |
Antibody Elisa Laboratories manufactures the elisa antibody titer protocol reagents distributed by Genprice. The Elisa Antibody Titer Protocol reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact antibody elisa. Other Elisa products are available in stock. Specificity: Elisa Category: Antibody Group: Titer Protocol
Lentivirus titer ELISA kit |
EnoGene |
96T |
EUR 901.59 |
Titer Protocol information
Mouse Anti-RABV Glycoprotein Antibody IgG Titer Serologic Assay Kit (ELISA) |
RAS-T157 |
ACROBIOSYSTEMS |
96tests |
EUR 631.3 |
|
Description: Rabies virus (RABV), scientific name Rabies lyssavirus, is a deadly neurotropic virus that causes rabies in humans and animals. Rabies virus has an extremely wide host range and its transmission most often occur through the saliva of animals. Without intervention prior to disease progression, rabies has the highest case fatality of any infectious disease. RABV contains a single-stranded negative-sense RNA genome that encodes five structural proteins: nucleoprotein (N), phosphoprotein (P), matrix protein (M), glycoprotein (G), and RNA-dependent RNA polymerase (L). Among these viral proteins, the RABV glycoprotein (RABV-G) is a pivotal player mediating virus entry and the major target of neutralizing antibodies, thus a key factor for vaccine and drug design. |
QuickTiter Adenovirus Titer ELISA Kit |
MBS168539-2x96Assays |
MyBiosource |
2x96Assays |
EUR 835 |
High titer |
S501H |
101Bio |
100 µL ( > 1 x 10^8 IFU/mL ) |
EUR 1100 |
High titer |
S501HL |
101Bio |
200 µL ( > 1 x 10^8 IFU/mL ) |
EUR 1400 |
High titer |
S502H |
101Bio |
100 µL ( > 1 x 10^8 IFU/mL ) |
EUR 1100 |
QuickTiter™ Adenovirus Titer ELISA Kit |
VPK-110 |
Cell Biolabs |
2 x 96 assays |
EUR 630 |
Human Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0) |
RAS-T160 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly. Various approaches are being used to develop an effective RSV vaccine. The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development.To facilitate the RSV-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |
Mouse Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0) |
RAS-T161 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly. Various approaches are being used to develop an effective RSV vaccine. The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development.To facilitate the RSV-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |
Monkey Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0) |
RAS-T162 |
ACROBIOSYSTEMS |
96tests |
EUR 706.2 |
|
Description: Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly. Various approaches are being used to develop an effective RSV vaccine. The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development.To facilitate the RSV-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |
Mouse Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Post-Fusion glycoprotein F0) |
RAS-T168 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
Description: Most in vitro RSV neutralizing antibodies in human sera are directed against the prefusion conformation, but due to its instability the prefusion conformation has a propensity to prematurely refold into the stable postfusion conformation, both in solution and on the surface of the virions. An RSV F protein that has both high expression levels and maintains a stable prefusion conformation would, therefore, be a promising subunit vaccine candidate against RSV. To facilitate the RSV-related research, drug trials and vaccine development,a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |
Mouse Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Post-Fusion glycoprotein F0) |
RAS-T168-96tests |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
Description: Most in vitro RSV neutralizing antibodies in human sera are directed against the prefusion conformation, but due to its instability the prefusion conformation has a propensity to prematurely refold into the stable postfusion conformation, both in solution and on the surface of the virions. An RSV F protein that has both high expression levels and maintains a stable prefusion conformation would, therefore, be a promising subunit vaccine candidate against RSV. To facilitate the RSV-related research, drug trials and vaccine development,a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |
High titer Large |
S502HL |
101Bio |
200 µL ( > 1 x 10^8 IFU/mL ) |
EUR 1400 |
Ultra-high Titer |
S501U |
101Bio |
100 µL ( > 1 x 10^9 IFU/mL ) |
EUR 1700 |
Ultra-high Titer |
S502U |
101Bio |
100 µL ( > 1 x 10^9 IFU/mL ) |
EUR 1700 |
SARS-CoV-2 (B.1.1.529) Spike S1 Antibody Titer Assay Kit |
MBS8124214-5x96Tests |
MyBiosource |
5x96Tests |
EUR 3465 |
SARS-CoV-2 (B.1.1.529) Spike S1 Antibody Titer Assay Kit |
MBS8124214-96Tests |
MyBiosource |
96Tests |
EUR 750 |
Cotton Rat Anti-RSV-F0 Antibody IgG Titer ELISA Assay Kit (Pre-Fusion glycoprotein F0) |
RAS-T172 |
ACROBIOSYSTEMS |
96tests |
EUR 719.4 |
|
Description: Respiratory syncytial virus (RSV) is a highly contagious virus causing severe infection in infants and the elderly. Various approaches are being used to develop an effective RSV vaccine. The RSV fusion (F) subunit, particularly the cleaved trimeric pre-fusion F, is one of the most promising vaccine candidates under development.To facilitate the RSV-related research, drug trials and vaccine development, a high-throughput assay to measure IgG antibodies against the virus is in urgent need. |